Skip to main content
. 2007 Sep;62(9):767–772. doi: 10.1136/thx.2006.070847

Table 4 Net improvement in intervention and control groups at 12 months.

Intervention group Control group Difference in net % better (95% CI)*
Total No. better No. worse Net % better Total No. better No. worse Net % better
Breathing since baseline 86 50 5 52 76 24 6 24 29 (10 to 47)
Medication in last 6 months† 89 33 13 22 79 29 16 16 6 (−15 to 27)
Preventer in last 4 weeks 90 24 11 14 81 6 10 −5 19 (4 to 35)
Reliever in last 4 weeks 90 25 7 20 81 9 7 2 18 (2 to 33)
Wheeze in last 4 weeks 89 22 7 17 81 20 4 20 −3 (−19 to 12)
Wheeze disturbs sleep 89 30 10 22 81 35 4 38 −16 (−34 to 2)
Wheeze limits speech 87 11 1 11 81 6 3 4 8 (−2 to 18)
Wheeze affects activities 90 36 11 28 81 30 12 22 5 (−15 to 26)
Rhinitis 90 22 6 18 81 7 12 −6 24 (9 to 39)
Rhinoconjunctivitis 90 21 7 16 81 8 12 −5 20 (5 to 36)
Rhinitis affects activities 90 28 17 12 81 17 18 −1 13 (−7 to 33)

*Difference  =  value in intervention group minus value in control group.

†Perceived change in medication use in last 6 months compared with use before then.

For medication, preventers and relievers, “better” and “worse” denote less and more use respectively.